An estimated 30% of patients who are prescribed antidepressant medications do not have an adequate response. In order to address these high rates of nonresponse to standard depression therapies, researchers continue to explore a wide range of other promising agents, including anti-inflammatory therapies and psilocybin.
The dual pandemics of COVID-19 and racism as public health crises have led to an awakening among non-Black Americans as to how rampant racism is in the field of psychiatry and other mental health disciplines.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.
Only 65.2% of adults surveyed in United States in 2014 reported that they consistently get at least 7 hours of sleep each night.
Various studies have consistently shown associations between recessions and worsening mental health, as indicated by increased rates of depression.
It is critical for clinicians to be aware of the unique risks and potential drug interactions that may affect MDD patients.
When the spread of COVID-19 began to necessitate physical distancing, telemedicine was suddenly recast in many settings as the only option rather than just a feasible alternative to in-person care.
Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.
Major depressive disorder (MDD) is commonly observed in medical settings, with a prevalence of up to 14% compared with 2% to 4% in the general population.1 Various studies have found rates of 12% to 18% in patients with diabetes, 15% to 23% in those with coronary heart disease, 23% to 54% in patients with multiple…
